Publication | Open Access
Trends in Prescription Drug Launch Prices, 2008-2021
100
Citations
3
References
2022
Year
Population Health SciencesPharmacotherapyBrand-name Prescription DrugsClinical EpidemiologyClinical TrialsDrug MonitoringPublic HealthSsr Health DataDrug InteractionsHealth PolicyPharmacoeconomicsEconomic EvaluationPharmacologySubstance AbuseHealth EconomicsDrug DiscoveryHealth Services CompetitionManufacturer DiscountsMedicinePrescription Drugs
This study uses SSR Health data on drug list prices and estimated net prices after manufacturer discounts to evaluate trends in prices for newly marketed brand-name prescription drugs in the US from 2008 to 2021.
| Year | Citations | |
|---|---|---|
Page 1
Page 1